Clinical Trials
4
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)Early Parkinson's Disease Monotherapy With CVN424
Phase 2
Completed
- Conditions
- Parkinson's Disease
- Interventions
- Drug: CVN424 150 mgDrug: Placebo
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Cerevance Beta, Inc.
- Target Recruit Count
- 62
- Registration Number
- NCT06006247
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Relative Bioavailability and Food Effect Study of CVN424
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Cerevance Beta, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05635461
- Locations
- 🇺🇸
Celerion, Tempe, Arizona, United States
Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Phase 2
Completed
- Conditions
- Parkinson Disease
- Interventions
- Drug: CVN424 High DoseDrug: PlaceboDrug: CVN424 Low Dose
- First Posted Date
- 2019-12-10
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Cerevance Beta, Inc.
- Target Recruit Count
- 136
- Registration Number
- NCT04191577
- Locations
- 🇺🇸
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
🇺🇸SC3 Research - Pasadena, Pasadena, California, United States
🇺🇸Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
Study of CVN424 in Healthy Subjects
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Cerevance Beta, Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT03657030
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
News
No news found